The Bodily Complaints Barometer: The Impact of the Corona Measures and of Contracting a COVID-19 Infection on the Body.
Launched by UNIVERSITY GHENT · Dec 5, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
Since the start of the COVID-19 pandemic, almost half a billion people worldwide were infected with the new coronavirus, SARS-CoV-2, causing COVID-19 disease. In Belgium, 3.6 million people, a third of the population, contracted the disease. More than 30.000 patients did not survive this condition.
Many of those who did survive, however, complained of residual symptoms, even long after their infection. Initially the most reported and investigated complaints were lung and respiratory issues, but as time progressed, it became clear these were not the only residual problems after infection. A...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being at least 18 years old
- • Living and/or working in Belgium
- • Dutch speaking
- Exclusion Criteria:
- • Being younger than 18 years of age
- • Not working or living in Belgium during the pandemic and lockdown measures
Trial Officials
Jessica Van Oosterwijck, Prof
Study Director
Ghent University, Pain in Motion
About University Ghent
University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, Oost Vlaanderen, Belgium
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials